Travere Therapeutics, Inc. · NASDAQ:TVTX
Heerma Peter sold 2,174 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 5, 2026 · Filed May 6, 2026
From May 4 to May 5, 2026, Heerma Peter (CHIEF COMMERCIAL OFFICER) sold 2,174 Travere Therapeutics, Inc. shares at US$46.65 for US$101K, leaving 140,684 shares. Filed May 6, 2026 (Form 4).
- Sold
- 2,174 shares
- Price
- US$46.65
- Value
- US$101K
- Holding after
- 140,684 shares
- Trading plan
- No
- Role
- CHIEF COMMERCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 4,250 | 142,858 | Direct | |
| May 5, 2026 | Common Stock | Sale | 2,174 | US$46.65 | 140,684 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Heerma Peter
- Travere Therapeutics, Inc. shareholders
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Heerma Peter · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026